SCN2A and epilepsy: Given that the predominant expression of Nav1.1 is in inhibitory neurons and that of Nav1.2 is in excitatory neocortical/hippocampal neurons, it seems reasonable that SCN1A loss- or SCN2A gain-of-function mutations lead to epilepsies.